Bhubaneswar: State Government on Friday constituted an expert committee to examine the proposal of use of such drugs on case to case basis under the supervision of Director Medical Education and Training(DMET).
Committee will be headed by Dr.Bidyult Das., Professor Rheumatology SCB MCH Cuttack, (9437275220) as Chairman while the other members are Dr. Jyoti Patnaik, Professor Pulmonary Medicine SCB MCH Cuttack. (9437063213) and Dr. PK Thatoi, Professor Medicine, SCB MCH Cuttack (9437170150).
A Government notification said that it is noticed the number or Covid cases are increasing day by day due to Covid-I9 pandemic resurgence and Government is keen in providing the appropriate treatment to all such patients to reduce the mortality as well as morbidity to great extent.
There are certain drugs available for Covid patient management, which have restricted availability and also there are many newer drugs coming up with uncertain efficacy.
Many physicians and critical care specialists sometimes recommend such.
When any prescription is made for a Covid patient in a Covid facility with such newer, restricted available drug, the prescription shall come as a proposal to seek opinion regarding the judicious use of the drug.
Such proposal shaIl be sent to the Chairman of the Committee with an intimation to DMET, Odisha and MD OSMCL in Whatsapp. The requisition must be accompanied by the documents like, ID proof, Prescription of the treating doctor and Case sheet along with the investigation done.
The Committee will examine the records and certify the efficacy of the drug as well as the judiciousness use in the particular case. If considered for use, the recommendation shall be made to the MD OSMCL for the issue or the drug with intimation to the DMET Odisha by email /WhatsApp.
After obtaining such recommendation OSMCL will issue the drug as per the availability, said the notification